Cleared Traditional

K772152 - CENTRAL MONITORING SYSTEM

K772152 is an FDA 510(k) clearance for CENTRAL MONITORING SYSTEM, manufactured by Burdick Corp.. The device is a Class 2 Cardiovascular device with product code DXG cleared through the Traditional 510(k) pathway after a 13-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1977
Decision
13d
Days
Class 2
Risk

K772152 is an FDA 510(k) clearance for the CENTRAL MONITORING SYSTEM. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Burdick Corp. (Mchenry, US). The FDA issued a Cleared decision on November 28, 1977 after a review of 13 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Burdick Corp. devices

FDA 510(k) Submission Details - K772152

510(k) Number K772152 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 1977
Decision Date November 28, 1977
Days to Decision 13 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
112d faster than avg
Panel avg: 125d · This submission: 13d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXG Device Classification - Class 2, Special Controls

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 85
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K772152.
MODEL 656 ARRHYTHMIA ANALYZER
K792080 · Del Mar Avionics · Dec 1979
STORAGE, DIGITAL DSC-1, CONTROL UNIT
K790288 · Oxford Medilog, Inc. · Feb 1979
LVV OPTION
K781855 · Honeywell, Inc. · Jan 1979
LIGHT-PEN SYSTEM FOR QUANTI. ANALY.
K772158 · Varian Assoc., Inc. · Nov 1977
CARDIAC OUTPUT THERMODILUTION MODULE
K771991 · Abbott Laboratories · Nov 1977
CARDIAC CATHETERIZATION LAB MONITOR SYS
K770179 · General Electric Co. · Apr 1977